Agilent Technologies Inc (A)
132.35
+0.29
(+0.22%)
USD |
NYSE |
Nov 22, 11:19
Agilent Technologies Enterprise Value: 39.10B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 39.10B |
| November 20, 2024 | 38.09B |
| November 19, 2024 | 37.27B |
| November 18, 2024 | 37.62B |
| November 15, 2024 | 37.66B |
| November 14, 2024 | 38.57B |
| November 13, 2024 | 39.74B |
| November 12, 2024 | 39.56B |
| November 11, 2024 | 39.61B |
| November 08, 2024 | 40.42B |
| November 07, 2024 | 41.27B |
| November 06, 2024 | 40.74B |
| November 05, 2024 | 41.50B |
| November 04, 2024 | 41.28B |
| November 01, 2024 | 40.48B |
| October 31, 2024 | 38.59B |
| October 30, 2024 | 38.93B |
| October 29, 2024 | 38.86B |
| October 28, 2024 | 38.95B |
| October 25, 2024 | 38.56B |
| October 24, 2024 | 38.70B |
| October 23, 2024 | 39.38B |
| October 22, 2024 | 39.50B |
| October 21, 2024 | 40.45B |
| October 18, 2024 | 41.04B |
| Date | Value |
|---|---|
| October 17, 2024 | 40.64B |
| October 16, 2024 | 41.12B |
| October 15, 2024 | 42.69B |
| October 14, 2024 | 42.60B |
| October 11, 2024 | 42.48B |
| October 10, 2024 | 42.17B |
| October 09, 2024 | 42.76B |
| October 08, 2024 | 42.70B |
| October 07, 2024 | 42.50B |
| October 04, 2024 | 42.81B |
| October 03, 2024 | 42.69B |
| October 02, 2024 | 43.26B |
| October 01, 2024 | 43.26B |
| September 30, 2024 | 43.82B |
| September 27, 2024 | 43.69B |
| September 26, 2024 | 43.32B |
| September 25, 2024 | 41.22B |
| September 24, 2024 | 41.92B |
| September 23, 2024 | 41.32B |
| September 20, 2024 | 41.40B |
| September 19, 2024 | 41.94B |
| September 18, 2024 | 41.09B |
| September 17, 2024 | 40.90B |
| September 16, 2024 | 40.89B |
| September 13, 2024 | 40.61B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
20.86B
Minimum
Mar 23 2020
55.70B
Maximum
Sep 03 2021
38.97B
Average
39.72B
Median
Jan 23 2024
Enterprise Value Benchmarks
| Bio-Rad Laboratories Inc | 8.694B |
| Bruker Corp | 10.71B |
| Azenta Inc | 1.613B |
| Harvard Bioscience Inc | 127.50M |
| Phibro Animal Health Corp | 1.347B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 282.00M |
| Revenue (Quarterly) | 1.578B |
| Total Expenses (Quarterly) | 1.245B |
| EPS Diluted (Quarterly) | 0.97 |
| Gross Profit Margin (Quarterly) | 54.18% |
| Profit Margin (Quarterly) | 17.87% |
| Earnings Yield | 3.64% |
| Operating Earnings Yield | 3.83% |
| Normalized Earnings Yield | 3.642 |